These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764 [TBL] [Abstract][Full Text] [Related]
23. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting. Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940 [TBL] [Abstract][Full Text] [Related]
24. Somatostatin receptor targeting with hydrophilic [ Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499 [TBL] [Abstract][Full Text] [Related]
25. Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model. Lewis JS; Laforest R; Lewis MR; Anderson CJ Cancer Biother Radiopharm; 2000 Dec; 15(6):593-604. PubMed ID: 11190491 [TBL] [Abstract][Full Text] [Related]
26. Radiosynthesis and Preclinical Evaluation of Maschauer S; Heilmann M; Wängler C; Schirrmacher R; Prante O Bioconjug Chem; 2016 Nov; 27(11):2707-2714. PubMed ID: 27715017 [TBL] [Abstract][Full Text] [Related]
27. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620 [TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis, and Biological Evaluation of Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911 [TBL] [Abstract][Full Text] [Related]
29. MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1. Rogers BE; Parry JJ; Andrews R; Cordopatis P; Nock BA; Maina T J Nucl Med; 2005 Nov; 46(11):1889-97. PubMed ID: 16269604 [TBL] [Abstract][Full Text] [Related]
30. Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Lewis JS; Lewis MR; Cutler PD; Srinivasan A; Schmidt MA; Schwarz SW; Morris MM; Miller JP; Anderson CJ Clin Cancer Res; 1999 Nov; 5(11):3608-16. PubMed ID: 10589778 [TBL] [Abstract][Full Text] [Related]
31. DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Li WP; Lewis JS; Kim J; Bugaj JE; Johnson MA; Erion JL; Anderson CJ Bioconjug Chem; 2002; 13(4):721-8. PubMed ID: 12121126 [TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model. Petersen AL; Binderup T; Jølck RI; Rasmussen P; Henriksen JR; Pfeifer AK; Kjær A; Andresen TL J Control Release; 2012 Jun; 160(2):254-63. PubMed ID: 22245688 [TBL] [Abstract][Full Text] [Related]
33. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies. Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558 [TBL] [Abstract][Full Text] [Related]
34. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Ginj M; Zhang H; Waser B; Cescato R; Wild D; Wang X; Erchegyi J; Rivier J; Mäcke HR; Reubi JC Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16436-41. PubMed ID: 17056720 [TBL] [Abstract][Full Text] [Related]
35. Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues. Waser B; Tamma ML; Cescato R; Maecke HR; Reubi JC J Nucl Med; 2009 Jun; 50(6):936-41. PubMed ID: 19443580 [TBL] [Abstract][Full Text] [Related]
36. Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging. Liu Z; Pourghiasian M; Bénard F; Pan J; Lin KS; Perrin DM J Nucl Med; 2014 Sep; 55(9):1499-505. PubMed ID: 24970911 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy. De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of Fonseca Cabrera GO; Ma X; Lin W; Zhang T; Zhao W; Pan L; Li X; Barnhart TE; Aluicio-Sarduy E; Deng H; Wu X; Rakesh KP; Li Z; Engle JW; Wu Z J Nucl Med; 2024 Aug; 65(8):1250-1256. PubMed ID: 38871388 [TBL] [Abstract][Full Text] [Related]
39. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948 [TBL] [Abstract][Full Text] [Related]
40. A Cyanine-Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation. Heing-Becker I; Grötzinger C; Beindorff N; Prasad S; Erdmann S; Exner S; Haag R; Licha K Chembiochem; 2021 Apr; 22(7):1307-1315. PubMed ID: 33238069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]